Nicox SA - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Nicox SA. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Nicox SA. The Group's principal activity is to develop nitric-oxide donating drugs targeting the therapeutic area. The Group offers biopharmaceutical therapeutics to treat ailments such as osteoarthritis, diabetes, inflammation and cardio metabolic diseases. The Group markets its products under the brand names Naproxcinod, NCX 4016 and NCX 6560. The Group also works in association with major pharmaceutical companies such as Pfizer, Merck and Group Ferrer. The Group operates in France.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report